Fennec Pharmaceuticals (FENC) Receivables - Net (2022 - 2025)
Historic Receivables - Net for Fennec Pharmaceuticals (FENC) over the last 4 years, with Q3 2025 value amounting to $19.3 million.
- Fennec Pharmaceuticals' Receivables - Net rose 4985.28% to $19.3 million in Q3 2025 from the same period last year, while for Sep 2025 it was $19.3 million, marking a year-over-year increase of 4985.28%. This contributed to the annual value of $12.9 million for FY2024, which is 4617.65% up from last year.
- As of Q3 2025, Fennec Pharmaceuticals' Receivables - Net stood at $19.3 million, which was up 4985.28% from $17.5 million recorded in Q2 2025.
- Fennec Pharmaceuticals' Receivables - Net's 5-year high stood at $19.3 million during Q3 2025, with a 5-year trough of $1.5 million in Q4 2022.
- In the last 4 years, Fennec Pharmaceuticals' Receivables - Net had a median value of $11.3 million in 2024 and averaged $10.0 million.
- In the last 5 years, Fennec Pharmaceuticals' Receivables - Net soared by 51045.75% in 2024 and then skyrocketed by 4215.4% in 2025.
- Fennec Pharmaceuticals' Receivables - Net (Quarter) stood at $1.5 million in 2022, then skyrocketed by 470.49% to $8.8 million in 2023, then soared by 46.18% to $12.9 million in 2024, then soared by 50.13% to $19.3 million in 2025.
- Its last three reported values are $19.3 million in Q3 2025, $17.5 million for Q2 2025, and $15.4 million during Q1 2025.